What is ClickDiagnostics?
ClickDiagnostics operates at the intersection of mobile telecommunications and public health infrastructure. Since its inception in 2008, the company has developed a robust platform that facilitates remote diagnosis, real-time health data collection, and comprehensive medical record analysis. By integrating these services, ClickDiagnostics enables medical practitioners to provide quality care in regions where traditional healthcare access is limited or non-existent. The company's market position is defined by its ability to partner with governments, NGOs, and health organizations to deploy scalable, mobile-first health interventions across Africa, South Asia, and the Americas. This strategic approach ensures that patient data is not only collected but effectively utilized to drive better clinical outcomes.
How much funding has ClickDiagnostics raised?
ClickDiagnostics has raised a total of $196.3M across 4 funding rounds:
Series A
$16M
Debt
$9.5M
Series B
$100.8M
Series C
$70M
Series A (2015): $16M, investors not publicly disclosed
Debt (2018): $9.5M, investors not publicly disclosed
Series B (2020): $100.8M, investors not publicly disclosed
Series C (2020): $70M featuring Pitango Venture Capital, Cedars-Sinai, and John Doerr
Key Investors in ClickDiagnostics
Pitango Venture Capital
A prominent venture capital firm that partners with visionary entrepreneurs, providing value-added support across various sectors including HealthTech.
Cedars-Sinai
A non-profit academic medical center in the U.S. that provides specialized clinical programs and community-focused health initiatives.
John Doerr
A prominent venture capitalist and investor known for supporting high-growth technology companies and innovation-driven enterprises.
What's next for ClickDiagnostics?
With this recent capital, ClickDiagnostics is well-positioned to scale its tele-consultation infrastructure and enhance its medical record analysis capabilities. The company's growth trajectory, evidenced by its progression from Series A to Series C, suggests a focus on deepening its penetration in emerging markets while refining its diagnostic algorithms. Future strategic initiatives will likely involve expanding partnerships with academic medical centers and health systems to integrate its platform into broader public health frameworks. As mobile connectivity continues to proliferate globally, ClickDiagnostics is poised to capitalize on the increasing demand for ubiquitous, remote-access healthcare solutions, ensuring that its technology remains at the forefront of the digital health revolution.
See full ClickDiagnostics company page
